Scaling a Biotech Business: Lessons on Pivoting & Growth from Affinity Immuno

About this episode

Amir discusses her journey into science and the growth and pivoting strategies of Affinity Immuno during the pandemic.

Amir describes a non-linear path into science, switching from social sciences after rediscovering biology and finding organic chemistry intuitive and creative. She explains her PhD work at the University of Calgary in carbohydrate chemistry, synthesizing tumor-associated carbohydrates to support vaccine and detection research. Amir outlines how Affinity Immuno started with off-the-shelf ELISA kits, grew within PEI’s expanding biotech ecosystem, and pivoted during COVID-19 to pandemic re...

People in this episode

Guest: Amir

Topics covered

• biotech
• growth
• pivoting
• vaccine research
• carbohydrate chemistry

Keywords

• biotech business
• Affinity Immuno
• carbohydrate chemistry
• vaccine research
• COVID-19

Mentioned in this episode

Organizations: Affinity Immuno, University of Calgary

Places: PEI

More episodes of Pathways in Life Science

• The Gritty Reality of a Gene Therapy Scientist in 2026 · April 28, 2026 · 10 min
• The Roadies of Pharma: Is the MSL Life Your Next Big Gig? · April 14, 2026 · 9 min
• Synthetic Biology Architect: Why We’re Programming Cells Like Software. · March 29, 2026 · 8 min
• The Power of Storytelling in Biotech: Interview with Paul Naphtali from Genowrite · January 30, 2026 · 31 min
• The Future of Digital Pathology: AI, Remote Diagnosis, and Career Paths with David Remedios · January 6, 2026 · 35 min
• Lessons in Sales from a Former History Teacher · August 5, 2025 · 37 min